Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Gibson, P. R.; Muir, J.G.
July 2005
Gut;Jul2005, Vol. 54 Issue 7, p900
Academic Journal
Luminal delivery of phosphatidyl rich phospholipids appears to reduce mucosal inflammatory activity in a high proportion of patients with chronically active ulcerative colitis. The simplicity and apparent safety of this therapeutic approach offers new insights into the importance of the mucus barrier in the pathogenesis and treatment of ulcerative colitis.


Related Articles

  • Balsalazide achieved symptomatic remission sooner than mesalamine for ulcerative colitis. Pruitt, R.; Hanson, J.; Safdi, M.; McDonald, John W.D. // ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p71 

    Summarizes a study that investigated whether treatment with balsalazide achieves higher symptomatic remission rates than mesalamine in patients with active, mild-to-moderate ulcerative colitis. Characterization of the patients; Main outcome measures; Results of the study.

  • DILATATION OF THE COLON, A SERIOUS COMPLICATION OF ULCERATIVE COLITIS. Korelitz, B.I.; Janowitz, H.D. // Annals of Internal Medicine;Jul60, Vol. 53 Issue 1, p153 

    Presents two representative cases of dilatation of the colon as a serious complication of ulcerative colitis. Survey of literature on the disorder; Details of the case reports.

  • Abnormalities in colonic mucin may contribute to the persistence of colonic mucosal inflammation.  // Journal of Gastroenterology;2000, Vol. 35 Issue 1, p71 

    Editorial. Deals with the possible contribution of the abnormalities in colonic mucin to the persistence of colonic mucosal inflammation. Percentage of ulcerative colitis patients with circulating antibodies to colonocytes; Number of reported mucin genes; Description of MUC2 mucin; Candidate...

  • Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China. Tai, Wei-Ping; Hu, Pin-Jin; Wu, Jing; Lin, Xiang-Chun // Parasitology Research;May2011, Vol. 108 Issue 5, p1207 

    Blastocystis hominis is an enteric parasite which has long been considered as an innocuous commensal living in the intestinal tract. Our research was to explore the role of B. hominis in refractory ulcerative colitis. Our department admitted 122 cases of ulcerative colitis patients. In these...

  • Strategies to Improve Adherence and Outcomes in Patients with Ulcerative Colitis. Kane, Sunanda V. // Drugs;2008, Vol. 68 Issue 18, p2601 

    This review examines studies of patient adherence to 5-aminosalicylic acid therapy conducted outside the context of a controlled therapy trial, considers the reasons why patients do not adhere to their medication and its consequences, and interventions to improve adherence and disease outcomes....

  • A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis. van Deventer, S. J. H.; Tami, J. A.; Wedel, M. K. // Gut;Dec2004, Vol. 53 Issue 12, p1646 

    Objective: To evaluate the safely and efficacy of an enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule, after 1, 3, and 6 months. Methods: This was a randomised, placebo controlled, double blind, escalating dose multicentre study in 40 patients with mild...

  • Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Higgins, P. D. R.; Schwartz, M.; Mapili, J.; Krokos, I.; Leung, J.; Zimmermann, E. M. // Gut;Jun2005, Vol. 54 Issue 6, p782 

    Background and aims: Ulcerative colitis disease activity indices offer good statistical power but small changes in these indices may not be clinically important. There are no validated definitions of remission or of significant improvement for these indices. The use of clinically important end...

  • Comparative study of enema retention and preference in ulcerative colitis. Ingram, J. R.; Rhodes, J.; Evans, B. K.; Newcombe, R. G.; Thomas, G. A. O. // Postgraduate Medical Journal;Sep2005, Vol. 81 Issue 959, p594 

    Background: Therapeutic enemas are often used to treat active colitis but their retention may be limited because of urgency to defecate. Some preparations may be better retained and tolerated than others because of their physical properties. Aim: To compare patient preference and retention of...

  • Colonic obstruction due to giant inflammatory polyposis in a patient with ulcerative colitis. Yada, Shinichiro; Matsumoto, Takayuki; Kudo, Tetsuji; Hirahashi, Minako; Yao, Takashi; Mibu, Ryuichi; Iida, Mitsuo // Journal of Gastroenterology;May2005, Vol. 40 Issue 5, p536 

    A 32-year-old Japanese woman with a 14-month history of ulcerative colitis (UC), pancolitis type, was referred to our institution, because of abdominal distention. Plain abdominal X-ray and computed tomography (CT) showed marked dilatation of the right side of the colon. The patient was treated...


Read the Article


Sign out of this library

Other Topics